PEP: Meaning, Emergency HIV Prevention, Timing, and Treatment

A person should seek PEP immediately rather than waiting for symptoms or test results. HIV exposure is time-sensitive, and every hour matters.

Simple examples include:

• PEP may be offered after certain condomless sexual exposures.
• PEP may be needed when a condom breaks during sex.
• PEP may be offered after sharing injection equipment.
• A healthcare worker may receive PEP after a needlestick injury.
• PEP should be started no later than 72 hours after possible HIV exposure.

PEP does not mean that HIV transmission definitely occurred. It is preventive treatment used when an exposure may present a meaningful risk.

• take PEP;
• start PEP;
• receive PEP;
• complete PEP;
• ask about PEP.

Examples include:

• She started PEP after a possible exposure.
• He completed 28 days of PEP.
• They went to an emergency department to request PEP.

Do not normally say a PEP when referring to the treatment method. More natural expressions include:

• a PEP regimen;
• a course of PEP;
• PEP medication;
• a PEP prescription.

Common Usage Patterns

The term commonly appears in phrases such as:

• emergency PEP;
• HIV PEP;
• start PEP;
• complete PEP;
• PEP after sex;
• PEP after sexual assault;
• occupational PEP;
• transition from PEP to PrEP.

Possible situations include:

• condomless vaginal or anal sex with a person whose HIV status or viral suppression is uncertain;
• a condom breaking or slipping during sex;
• sexual assault involving possible HIV exposure;
• sharing needles, syringes, or other injection equipment;
• a needlestick or blood exposure in a healthcare or occupational setting;
• blood or certain sexual fluids contacting broken skin or a mucous membrane.

Not every contact presents a substantial HIV risk. A clinician considers the bodyfluid involved, type of contact, timing, source person’s HIV status and viral load, use of PrEP, and other relevant circumstances.

PEP is not generally needed after contact involving intact skin, ordinary social contact, saliva alone, hugging, sharing food, or using the same toilet.

The first dose should be taken:

• as soon as possible;
• ideally within 24 hours;
• no later than 72 hours after exposure.

The CDC’s 2025 nonoccupational PEP recommendations state that treatment should begin immediately when indicated and should not be delayed while laboratory test results are pending.

Someone seeking care more than 72 hours after exposure should still obtain HIV testing, medical advice, and a follow-up prevention plan. PrEP may be recommended for possible future exposure.

If treatment starts quickly enough, the medicines may prevent a small amount of virus from establishing a permanent infection.

PEP is highly protective when:

• it begins promptly;
• the correct medicines are used;
• every dose is taken as prescribed;
• the full 28-day course is completed;
• follow-up testing is performed.

PEP cannot guarantee prevention, and it cannot cure an HIV infection that was already established before treatment began.

• emergency departments;
• urgent-care centers;
• sexual-health clinics;
• HIV clinics;
• infectious-disease services;
• occupational-health departments;
• specially authorized pharmacies or community programs.

A person should clearly state that a possible HIV exposure occurred and say when it happened.

PEP should not be delayed because the person feels embarrassed, cannot contact the source, or does not know the source’s HIV status.

Evaluation may include:

• an HIV test;
• questions about the exposure;
• kidney and liver testing;
• pregnancy testing when relevant;
• hepatitis B and hepatitis C testing;
• screening for other STIs;
• review of medicines, allergies, and health conditions.

The first PEP dose may be given before all laboratory results return.

A negative HIV test immediately after exposure cannot rule out infection from that recent event. Follow-up testing is therefore necessary.

The exact medication regimen is selected according to:

• age and body weight;
• pregnancy or breastfeeding;
• kidney or liver health;
• possible drug interactions;
• previous HIV-prevention medicine;
• known drug resistance in the source;
• medication availability.

The World Health Organization’s PEP guidelines recommend rapid access, preferably within 24 hours, and a complete 28-day prescription.

A person should not change, share, or stop the medicines without professional advice. When the source is later confirmed not to have HIV, a clinician may advise stopping PEP.

Possible side effects include:

• nausea;
• diarrhea;
• headache;
• tiredness;
• stomach discomfort;
• difficulty sleeping.

Side effects are often mild and temporary. A clinician may provide treatment for them or change the regimen when necessary.

Missing doses may reduce protection. Helpful strategies include:

• taking PEP at the same time each day;
• using phone reminders;
• keeping medicine in a consistent location;
• planning for travel or work;
• contacting the clinic before medication runs out.

Vomiting soon after a dose, missing several doses, or experiencing severe symptoms should be discussed promptly with a healthcare professional.

Current US recommendations commonly include:

• an early follow-up contact, often within 24 hours;
• clinical and laboratory follow-up around four to six weeks after exposure;
• final HIV testing around twelve weeks after exposure.

Testing schedules may differ according to the type of HIV test, medications used, pregnancy, ongoing exposure, and national guidance.

Until follow-up is complete, the person may be advised to use appropriate prevention methods and avoid donating blood, semen, organs, or breast milk.

• PEP is started after an emergency exposure.
• PrEP is used before possible future exposure.
• PEP normally lasts 28 days.
• PrEP may continue while ongoing protection is wanted.

Someone who has repeated exposures or needs PEP more than once should discuss moving directly from PEP to PrEP.

The HIV.gov PEP overview explains that people with continuing exposure may transition to PrEP after completing emergency treatment.

• gonorrhea;
• chlamydia;
• syphilis;
• herpes;
• HPV;
• most forms of hepatitis;
• pregnancy.

A medical visit after possible exposure may also include:

• STI testing;
• preventive treatment in selected situations;
• hepatitis vaccination;
• emergency contraception;
• pregnancy testing;
• counseling about condoms and other barriers.

A person may have an STI without visible symptoms.

Care should be trauma-informed and may also include:

• treatment of injuries;
• testing or prevention for other STIs;
• emergency contraception;
• forensic examination when chosen;
• emotional support;
• safety planning.

A survivor should not be blamed for the exposure. Accepting or declining a forensic report should not determine whether urgent medical care is provided.

A healthcare professional should select a suitable regimen and discuss:

• possible benefits and side effects;
• medication interactions;
• pregnancy-related health needs;
• infant-feeding considerations;
• follow-up testing.

Pregnancy should not be used as a reason to delay urgent PEP assessment.

Using PEP does not prove that someone:

• has HIV;
• was sexually irresponsible;
• has multiple partners;
• is gay or bisexual;
• uses injection drugs;
• consented to the exposure.

PEP use and HIV testing are private health information. No partner, employer, family member, or healthcare worker should shame someone for requesting prevention.

PEP also does not replace sexual consent. Taking medicine after an exposure does not excuse assault, condom removal without agreement, or violation of safer-sex boundaries.

PEP is taken as a single dose.
HIV PEP normally requires daily medicine for 28 days.

PEP and PrEP are the same.
PEP is emergency treatment after exposure; PrEP is prevention used before exposure.

PEP prevents every STI and pregnancy.
It specifically reduces HIV risk.

A negative test immediately after exposure means PEP is unnecessary.
A new infection may be too early to detect, so risk assessment and follow-up are needed.

Requesting PEP means someone has HIV.
PEP is intended for people who do not have HIV or whose status has not yet been confirmed.

1. PEP is emergency HIV-prevention medicine taken after a possible exposure.
2. PEP should be started as soon as possible and no later than 72 hours afterward.
3. Can PEP prevent gonorrhea or pregnancy?
4. The patient began PEP after a condom broke during sex.
5. The healthcare worker received PEP after a needlestick injury.
6. Completing all 28 days of PEP gives the treatment its best chance of working.
7. Follow-up HIV testing remained necessary after PEP ended.
8. PEP may be used during pregnancy when clinically appropriate.
9. The survivor was offered PEP as part of confidential post-assault care.
10. After finishing PEP, the patient transitioned to PrEP for continuing protection.

PEP does not prevent most other STIs or pregnancy, and it does not replace condoms, PrEP, testing, communication, or consent. Seeking PEP does not reveal someone’s orientation, behavior, or moral character.

Accurate sexuality education emphasizes immediate access within 72 hours, completion of the 28-day course, follow-up HIV testing, confidential and nonjudgmental care, and transition to PrEP when future exposure may continue.